Summary of Changes
- Updates to IFI wound epidemiology to include surgical and wound healing outcomes
- Addition of pan-fungal PCR as a potential rapid molecular diagnostic modality
- Updates on the use of IV voriconazole in those with impaired renal function
- Updates on posaconazole administration
- Addition of isavuconazole as a mold active triazole
- Addition of tissue sample handling considerations to increase culture yield of fungi (i.e. Mucor)
- Updated Jul 2021 with the Dakin’s half-strength solution